Serum CCL17 level becomes a predictive marker to distinguish between mild/moderate and severe/critical disease in patients with COVID-19-Reference-Cited by-同舟云学术

Serum CCL17 level becomes a predictive marker to distinguish between mild/moderate and severe/critical disease in patients with COVID-19

Published:2021-01 Issue: Volume:766 Page:145145
ISSN:0378-1119
Container-title:Gene
language:en
Short-container-title:Gene

Author:

Sugiyama Masaya,Kinoshita Noriko,Ide Satoshi,Nomoto Hidetoshi,Nakamoto Takato,Saito Sho,Ishikane Masahiro,Kutsuna Satoshi,Hayakawa Kayoko,Hashimoto Masao,Suzuki Manabu,Izumi Shinyu,Hojo Masayuki,Tsuchiya Kiyoto,Gatanaga Hiroyuki,Takasaki Jin,Usami Masahide,Kano Toshikazu,Yanai Hidekatsu,Nishida Nao,Kanto Tatsuya,Sugiyama Haruhito,Ohmagari Norio,Mizokami Masashi

Funder

Japan Agency for Medical Research and Development

Publisher

Elsevier BV

Subject

Genetics,General Medicine

Reference42 articles.

1. Prediction of severe illness due to COVID-19 based on an analysis of initial Fibrinogen to Albumin Ratio and Platelet count;Bi;Platelets,2020

2. Type III interferons disrupt the lung epithelial barrier upon viral recognition;Broggi;Science,2020

3. Clinical and immunological features of severe and moderate coronavirus disease 2019;Chen;J. Clin. Invest.,2020

4. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study;Chen;Lancet,2020

5. Epidemiology, clinical course, and outcomes of critically ill adults with COVID-19 in New York City: a prospective cohort study;Cummings;Lancet,2020

Cited by 77 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Detailed tracking of antigen and antibody levels during coronavirus disease 2019 treatment in an immunosuppressed patient with anti-neutrophil cytoplasmic autoantibody-associated vasculitis;Journal of Infection and Chemotherapy;2024-09

2. Predictive biomarkers of COVID-19 prognosis identified in Bangladesh patients and validated in Japanese cohorts;Scientific Reports;2024-06-03

3. Identification of CXCL9 chemokine as a potential biomarker for assessing clinical severity in COVID-19 patients;The Journal of Infection in Developing Countries;2024-05-30

4. Possibilities of neural network analysis in determining the severity form of new coronavirus infection in school-age children;Astrakhan medical journal;2024-04-11

5. Monocyte-to-Hdl-Cholesterol Ratio as a Prognostic Marker in Covid-19;Journal of Pioneering Medical Science;2024-02-29